Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents

BACKGROUND: The increasing incidence of pediatric hospitalizations associated with coronavirus disease 2019 (Covid-19) caused by the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States has offered an opportunity to assess the real-world effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, Samantha M., Newhams, Margaret M., Halasa, Natasha B., Price, Ashley M., Boom, Julie A., Sahni, Leila C., Pannaraj, Pia S., Irby, Katherine, Walker, Tracie C., Schwartz, Stephanie P., Maddux, Aline B., Mack, Elizabeth H., Bradford, Tamara T., Schuster, Jennifer E., Nofziger, Ryan A., Cameron, Melissa A., Chiotos, Kathleen, Cullimore, Melissa L., Gertz, Shira J., Levy, Emily R., Kong, Michele, Cvijanovich, Natalie Z., Staat, Mary A., Kamidani, Satoshi, Chatani, Brandon M., Bhumbra, Samina S., Bline, Katherine E., Gaspers, Mary G., Hobbs, Charlotte V., Heidemann, Sabrina M., Maamari, Mia, Flori, Heidi R., Hume, Janet R., Zinter, Matt S., Michelson, Kelly N., Zambrano, Laura D., Campbell, Angela P., Patel, Manish M., Randolph, Adrienne G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781318/
https://www.ncbi.nlm.nih.gov/pubmed/35021004
http://dx.doi.org/10.1056/NEJMoa2117995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781318/
https://www.ncbi.nlm.nih.gov/pubmed/35021004
http://dx.doi.org/10.1056/NEJMoa2117995

Ejemplares similares